Histopathological and Molecular Changes during Apoptosis Produced by 7H-Dibenzo[c,g]-Carbazole in Mouse Liver

Toxicologic Pathology

Volumn 32, Issue 2, 2004, Pages 202-211

  Martín Burriel, Inmaculada ^a,b   Roome, Nigel O ^a   Dorchies, Olivier ^a   Prenez, Annick ^a  

^a SANOFI   (France)

^b Lab Genet Bioquim Grupos S   (Spain)

Author keywords

Apoptosis; Bax; Bcl 2; Dibenzocarbazole; Fas; Liver; Mouse; p53

Indexed keywords

7H DIBENZO[C,G]CARBAZOLE; BIOLOGICAL MARKER; CARBAZOLE DERIVATIVE; FAS ANTIGEN; INHIBITOR OF APOPTOSIS PROTEIN; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA ADDUCT; EXPOSURE; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; GENOTOXICITY; HISTOPATHOLOGY; LIVER; LIVER PARENCHYMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADMINISTRATION, TOPICAL; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARBAZOLES; CARCINOGENS; CELL NUCLEUS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; IN SITU NICK-END LABELING; LIVER; MICE; MICE, INBRED DBA; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

ANIMALIA;

EID: 1842563795     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1080/01926230490274353     Document Type: Article

References (53)

1. Bartek, J., Bartkova, J., Vojtesek, B., Staskova, Z., Rejthar, A., Kovarik, J., and Lane, D. P. (1990). Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro. Int J Cancer 46, 839-44.
2. Bedossa, P., Peltier, E., Terris, B., Franco, D., and Poynard, T. (1995). Transforming growth factor β1 (TGF-β1) and TGF-β1 receptors in normal, cirrhotic and neoplastic human livers. Hepatology 21, 760-6.
3. Binkova, B., Giguere, Y., Rossner, P., Dostal, M., and Sram, R. J. (2000). The effect of dibenzo(a,1)pyrene and benzo(a)pyrene on human diploid lung fibroblasts: the induction of DNA adducts, expression of p53 and p21(WAF1) proteins and cell cycle distribution. Mutat Res 971, 57-70.
4. Bjerlogrlic, N., Mäkinen, M., Stenbäck, F., and Vähäkanga, K. (1994). Benzo(a)pyrene-7,8-diol-9,10-epoxide-DNA adducts and increased p53 protein in mouse skin. Carcinogenesis 15, 771-4.
5. Braun, L., Gruppuso, P., Mikumo, R., and Fausto, N. (1990). Transforming growth factor beta 1 in liver carcinogenesis: messenger RNA expression and growth effects. Cell Growth Differ 1, 103-11.
6. Braun, L., Mead, J. E., Panzica, M., Mikumo, R., Bell, G. I., and Fausto, N. (1988). Transforming growth factor β mRNA increases during liver regeneration: a possible paracrine mechanism of growth regulation. Proc Natl Acad Sci USA 85, 1539-43.
7. Carlisle, D. L., Pritchard, D. E., Singh, J., Owens, B. M., Blanknship, L. J., Orenstein, J. M., and Patiermo, S. R. (2000). Apoptosis and p53 induction in human lung fibroblasts exposed to chromium (VI): effect of ascorbate and tocopherol. Toxicol Sci 55, 60-8.
8. Charlotte, F., Hermine, A. L., Martin, N., Geleyn, Y., Nollet, M., Gaulard, P., and Zafrani, E. S. (1994). Immunohistochemical detection of bcl-2 protein in normal and pathological human liver. Amer J Pathol 144, 460-5.
9. Czaja, M. J., Weiner, F. R., Flanders, K. C., Giambrone, R., Wind, L., Biempica, L., and Zem, M. A. (1989). In vitro and in vivo association of transforming growth factor β1 with hepatic fibrosis. J Cell Biol 108, 2477-82.
10. Denissenko, M. F., Koudriakova, T. B., Smith, L., O'Connor, T. R., Riggs, A. D., and Pfeifer, G. P. (1998). The p53 codon 249 mutational hotspot in hepatocellular carcinoma is not related to selective formation or persistence of aflatoxin B1 adducts. Oncogene 17, 3007-14.
11. Dorchies, O., Perin-Roussel, O., Gillardeaux, O., Vericat, J. A., Roome, N. O., Prenez, A., and Perin, F. (2001). Induction of DNA synthesis in mouse liver following increases of DNA adduct levels elicited by very low cumulative doses of the genotoxic hepatocarcinogen 7H-dibenzo(c,g)carbazole. Toxicol Pathol 29, 528-34.
12. Fausto, N., Mead, J. E., Gruppuso, P. A., and Braun, L. (1990). TGF-β in liver development regeneration and carcinogenesis. Ann NY Acad Sci 593, 231-42.
13. Fritsche, M., Haessler, C., and Brandner, G. (1993). Induction of nuclear accumulation of the tumour-suppressor protein p53 by DNA-damaging agents. Oncogene 8, 307-18.
14. Gilliland, G., Perrin, S., Blanchard, K., and Bunn, H. F. (1990). Analysis of cytokine mRNA and DNA: detection and quantification by competitive polymerase chain reaction. Proc Natl Acad Sci USA 87, 2725-9.
15. Gottlieb, T. M., and Oren, M. (1996). p53 in growth control and neoplasia. Biochem Biophys Acta 1287, 77-102.
16. Harnois, D. M., Que, F. G., Celli, A., LaRusso, N. F., and Gores, G. J. (1997). Bcl-2 is overexpressed and alters the threshold for apoptosis in a cholangiocarcinoma cell line. Hepatology 26, 884-90.
17. Kastan, M. B., Onyekwere, O., Sindransky, D., Vogelstein, B., and Craig, R. W. (1991). Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51, 6304-11.
18. Kobertz, W. R., Wang, D., Wogan, G. N., and Essigmann, J. M. (1997). An intercalation inhibitor altering the target selectivity of DNA damaging agents: synthesis of site-specific aflatoxin B1 adducts in a p53 mutational hotspot. Proc Natl Acad Sci USA 94, 9579-84.
19. Lane, D. P. (1992). p53, guardian of the genome. Nature 358, 15-6.
20. Levine, A. J. (1997). p53, the cellular gatekeeper for growth and division. Cell 88, 323-31.
21. Lim, I. K. (2002). Spectrum of molecular changes during hepatocarcinogenesis induced by DEN and other chemicals in Fisher 344 male rats. Mech Ageing Dev 123, 1665-80.
22. Liu, M., Dhanwada, K. R., Birt, D. F., Hecht, S., and Pelling, X. (1994). Increase inp53 protein half-life in mouse keratinocytes following UV-B irradiation. Carcinogenesis 15, 1089-92.
23. Mace, K., Aguilar, F., Wang, J. S., Vautravers, P., Gomez-Lechon, M., Gonzalez, F. J., Groopman, J., Harris, C. C., and Pfeifer, A. M. (1997). Aflatoxin B1-induced DNA adduct formation and p53 mutations in CYP450-expressing human liver cell lines. Carcinogenesis 18, 1291-7.
24. Mitry, R. R., Sarraf, C. E., Chuang-Ging, W., Pignatelli, M., and Habib, N. A. (1997). Wild-type p53 induces apoptosis in Hep3B trough up-regulation of Bax expression. Lab Invest 77, 369-78.
25. Miyashita, T., Krajewski, S., Krajeweski, M., Wang, H. G., Lin, H. K., Liebermann, D. A., Hoffman, B., and Reed, J. C. (1994). Tumour suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9, 1799-805.
26. Moll, U. M., Ostermeyer, A. G., Haladay, R., Winkfield, B., Frazier, M., and Zambetti, G. (1996). Cytoplasmic sequestration of wild-type p53 protein impairs the G1 checkpoint after DNA damage. Mol Cell Biol 16, 1126-37.
27. Muller, M., Strand, S., Hug, H., Heinemann, E. M., Walzack, H., Hofmann, W. J., Stremmel, W., Krammer, P. H., and Galle, P. R. (1997). Drug induced apoptosis in hepatoma cells is mediated by the CD95(APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J Clin Invest 99, 403-13.
28. Oberhammer, F. A., Pavelka, M., Sharma, S., Tiefenbacher, R., Purchio. A. F., Bursch, W., and Schulte-Hermann, R. (1992). Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor β1 (mature and latent transforming growth factor β1). Proc Natl Acad Sci USA 89, 5408-12.
29. O'Brien, T., Babcock, G., Comelius, J., Dingeldein, M., Talaska, G., Warshawsky, D., and Mitchell, K. (2000). A comparison of apoptosis and necrosis induced by hepatotoxins in HepG2 cells. Toxicol Appl Pharmacol 164, 280-90.
30. Owen-Schaub, L. B., Zhang, W., Cusack, J. C., Angelo, L. S., Santee, S. M., Fujiwara, T., Roth, J. A., Deisseroth, A. B., Zhang, W. W., Kruzel, E., and Radinsky, R. (1995). Wild type human p53 and temperature-sensitive mutant induce Fas/APO1 expression. Mol Cell Biol 15, 3032-40.
31. Patel, T., and Gores, G. J. (1995). Apoptosis and hepatobiliary disease. Hepatology 21, 1725-41.
32. Périn-Roussel, O., Périn, F., Barat, N., Plessis, M. J., and Zajdela, F. (1995). Interaction of 7H-dibenzo[c,g]carbazole and its organospecific derivates with hepatic mitochondrial and nuclear DNA in the mouse. Environ Mol Mutagen 25, 202-10.
33. Périn, F., Valéro, D., Mispelter, J., and Zajdela, F. (1984). In vitro metabolism of N-methyl-dibenzo(c,g)carbazole, a potent sarcomatogen devoid of hepatotoxic and hepatocarcinogenic properties. Chem Biol Interact 48, 281-95.
34. Périn, F., Valéro, D., Thybaud-Lambay, V., Plessis, M. J., and Zajdela, F. (1988). Organ specific, carcinogenic dibenzo[c,g]carbazole derivatives: discriminative response in S.Typhimurium TA 100 mutagenesis modulated by sub-cellular fractions of mose liver. Mutat Res 198, 15-26.
35. Rämet, M., Castrén, K., Järvinen, K., Pekkala, K., Turpeenniemi-Hujanen, T., Soini, Y., Pääkkö, P., and Vähäkangas, K. (1995). p53 protein expression is correlated with benzo(a)pyrene-DNA adducts in carcinoma cell lines. Carcinogenesis 16, 2117-24.
36. Roberts, A. B., Thompson, N. L., Heine, U., Flanders, C., and Spom, M. B. (1988). Transforming growth factor-β: possible roles in carcinogenesis. Br J Cancer 57, 594-600.
37. Russell, W. E., Coffey, R. J., Jr., Ouellette, A. J., and Moses, H. L. (1988). Type β transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc Natl Acad Sci USA 85, 5126-30.
38. Ryan, J. J., Prochownick, E., Gottlieb, C. A., Apel, I. J., Merino, R., Nuñez, G., and Clarke, M. F. (1994). c-myc and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle. Proc Natl Acad Sci USA 91, 5878-82.
39. Selvey, S., Thompson, E. W., Matthaei, K., Lea, R. A., Irving, M. G., and Griffiths, L. R. (2001) β-Actin an unsuitable intemal control for RT-PCR. Mol Cell Probes 15, 307-11.
40. Shaulsky, G., Goldfinger, N., Peled, A., and Rotter, V. (1991). Involvement of wild-type p53 protein in the cell cycle requires nuclear localization. Cell Growth Differ 2, 661-7.
41. Sporn, M. B., and Roberts, A. B. (1985). Autocrine growth factors and cancer. Nature 313, 745-7.
42. Stommel, J. M., Marchenko, N. D., Jimenez, G. S., Moll, U. M., Hope, T. J., and Whal, G. M. (1999). A leucine-rich nuclear export signal in the p53 tetrameization domain: regulation of subcellular localization and p53 activity by NES masking. EMBO J 18, 1660-72.
43. Tombolan, F., Renault, D., Brault, D., Guffroy, M., Périn-Roussel, O., Périn, F., and Thybaud, V. (1999a). Kinetics of induction of DNA adducts, cell proliferation and gene mutations in the liver of MutaTM mice treated with 5,9-dimethyl-dibenzo[c,g]carbazole. Carcinogenesis 20, 125-32.
44. Tombolan, F., Renault, D., Brault, D., Guffroy, M., Périn, F., and Thybaud, V. (1999b). Effect of mitogenic or regenerative cell proliferation on lacZ mutant frequency in the liver of MutaTMMice treated with 5,9-dimethyl-dibenzo[c,g]carbazole. Carcinogenesis 20, 1357-999.
45. Valéro, D., Perin, F., Plessis, M. J., and Zajdela, F. (1985). Sexual differences in the expression of gamma-glutamyl transpeptidase during 5,9-dimethyl-dibenzo[c,g]carbazole induced hepatocarcinogenesis in mouse. Cancer Lett 27, 181-7.
46. van Gijssel, H. E., Maassen, C. B. M., Mulder, G. J., and Meerman, J. H. N. (1997). p53 protein expression by hepatocarcinogens in the rat liver and its potential role in mitoinhibition of normal hepatocytes as a mechanism of hepatic tumour progression. Carcinogenesis 18, 1027-33.
47. Vogelstein, B., and Kinzler, K. W. (1992). p53 function and dysfunction. Cell 70, 523-6.
48. Wang, A. M., Doyle, M. V., and Mark, D. F. (1989). Quantification of mRNA by the polymerase chain reaction. Proc Natl Acad Sci USA 86, 9717-21.
49. Washawsky, D., Talaska, G., Jue, W., and Schneider, J. (1996). Comparative carcinogenicity, metabolism, mutagenicity and DNA binding of 7H-dibenzo(c,g)carbazole and dibenzo(a,j)acridine. Crit Rev Toxicol 26, 213-49.
50. Wolter, K. G., Hsu, Y. T., Smith, C. L., Nechushtan, A., Xi, X. G., and Youle, R. J. (1997). Movement of Bax from the cytosol to mitochondria during apoptosis. J Cell Biol 139, 1281-92.
51. Yin, C., Knudson, C. M., Korsmeyer, S. J., and van Dyke, T. (1997). Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature 385, 637-40.
52. Yoshizawa, K., Nambu, H., Yang, J., Oishi, Y., Senzaki, H., Shikata, N., Miki, H., and Tsubura, A. (1999). Mechanisms of photoreceptor cell apoptosis induced by N-methyl-N-nitrosurea in Sprague-Dawley rats. Lab Invest 79, 1359-67.
53. Zhang, X., Wang, T., Batist, G., and Tsao, M. S. (1994). Transforming growth factor β1 promotes spontaneous transformation of cultured rat liver epithelial cells. Cancer Res 54, 6122-8.